These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30923528)

  • 1. Leucocyte Trafficking via the Lymphatic Vasculature- Mechanisms and Consequences.
    Jackson DG
    Front Immunol; 2019; 10():471. PubMed ID: 30923528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx.
    Johnson LA; Banerji S; Lagerholm BC; Jackson DG
    Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33687996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan and Its Receptors: Key Mediators of Immune Cell Entry and Trafficking in the Lymphatic System.
    Johnson LA; Jackson DG
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling.
    Tal O; Lim HY; Gurevich I; Milo I; Shipony Z; Ng LG; Angeli V; Shakhar G
    J Exp Med; 2011 Sep; 208(10):2141-53. PubMed ID: 21930767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and Immune Function of Afferent Lymphatics and Their Mechanistic Contribution to Dendritic Cell and T Cell Trafficking.
    Arasa J; Collado-Diaz V; Halin C
    Cells; 2021 May; 10(5):. PubMed ID: 34065513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic trafficking of immune cells and insights for cancer metastasis.
    Jackson DG
    Clin Exp Metastasis; 2024 Aug; 41(4):381-386. PubMed ID: 37606814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.
    Johnson LA; Banerji S; Lawrance W; Gileadi U; Prota G; Holder KA; Roshorm YM; Hanke T; Cerundolo V; Gale NW; Jackson DG
    Nat Immunol; 2017 Jul; 18(7):762-770. PubMed ID: 28504698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking.
    Jackson DG
    Matrix Biol; 2019 May; 78-79():219-235. PubMed ID: 29425695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging leukocyte migration through afferent lymphatics.
    Collado-Diaz V; Medina-Sanchez JD; Gkountidi AO; Halin C
    Immunol Rev; 2022 Mar; 306(1):43-57. PubMed ID: 34708414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic Regulation of Cellular Trafficking.
    Jackson DG
    J Clin Cell Immunol; 2014 Oct; 5():. PubMed ID: 27808282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell traffic and the lymphatic endothelium.
    Johnson LA; Jackson DG
    Ann N Y Acad Sci; 2008; 1131():119-33. PubMed ID: 18519965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
    Gale NW; Prevo R; Espinosa J; Ferguson DJ; Dominguez MG; Yancopoulos GD; Thurston G; Jackson DG
    Mol Cell Biol; 2007 Jan; 27(2):595-604. PubMed ID: 17101772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.
    Das S; Sarrou E; Podgrabinska S; Cassella M; Mungamuri SK; Feirt N; Gordon R; Nagi CS; Wang Y; Entenberg D; Condeelis J; Skobe M
    J Exp Med; 2013 Jul; 210(8):1509-28. PubMed ID: 23878309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes.
    Rantakari P; Auvinen K; Jäppinen N; Kapraali M; Valtonen J; Karikoski M; Gerke H; Iftakhar-E-Khuda I; Keuschnigg J; Umemoto E; Tohya K; Miyasaka M; Elima K; Jalkanen S; Salmi M
    Nat Immunol; 2015 Apr; 16(4):386-96. PubMed ID: 25665101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node.
    Yin X; Johns SC; Kim D; Mikulski Z; Salanga CL; Handel TM; Macal M; Zúñiga EI; Fuster MM
    J Immunol; 2014 Mar; 192(5):2133-42. PubMed ID: 24493818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes.
    Mionnet C; Sanos SL; Mondor I; Jorquera A; Laugier JP; Germain RN; Bajénoff M
    Blood; 2011 Dec; 118(23):6115-22. PubMed ID: 21937697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium.
    Johnson LA; Clasper S; Holt AP; Lalor PF; Baban D; Jackson DG
    J Exp Med; 2006 Nov; 203(12):2763-77. PubMed ID: 17116732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction.
    Rigby DA; Ferguson DJ; Johnson LA; Jackson DG
    J Leukoc Biol; 2015 Dec; 98(6):897-912. PubMed ID: 26216937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different role of CD73 in leukocyte trafficking via blood and lymph vessels.
    Ålgars A; Karikoski M; Yegutkin GG; Stoitzner P; Niemelä J; Salmi M; Jalkanen S
    Blood; 2011 Apr; 117(16):4387-93. PubMed ID: 21346249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic-cell trafficking to lymph nodes through lymphatic vessels.
    Randolph GJ; Angeli V; Swartz MA
    Nat Rev Immunol; 2005 Aug; 5(8):617-28. PubMed ID: 16056255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.